Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 3
2010 5
2011 4
2012 4
2013 2
2017 1
2019 3
2020 3
2021 9
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.
Boers M, Hartman L, Opris-Belinski D, Bos R, Kok MR, Da Silva JA, Griep EN, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Klausch LT, Paolino S, Schilder AM, Lems WF, Cutolo M; GLORIA Trial consortium. Boers M, et al. Among authors: raterman hg. Ann Rheum Dis. 2022 Jul;81(7):925-936. doi: 10.1136/annrheumdis-2021-221957. Epub 2022 May 31. Ann Rheum Dis. 2022. PMID: 35641125 Free PMC article. Clinical Trial.
Management of glucocorticoid-induced osteoporosis.
Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W. Messina OD, et al. Among authors: raterman hg. Aging Clin Exp Res. 2021 Apr;33(4):793-804. doi: 10.1007/s40520-021-01823-0. Epub 2021 Mar 22. Aging Clin Exp Res. 2021. PMID: 33751462 Review.
Correction to: Management of glucocorticoid-induced osteoporosis.
Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W. Messina OD, et al. Among authors: raterman hg. Aging Clin Exp Res. 2022 Dec;34(12):3185. doi: 10.1007/s40520-021-01937-5. Epub 2021 Jul 23. Aging Clin Exp Res. 2022. PMID: 34297337 No abstract available.
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial.
Almayali AAH, Boers M, Hartman L, Opris D, Bos R, Kok MR, Da Silva JA, Griep E, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Lems W, Smulders Y, Cutolo M, Ter Wee MM. Almayali AAH, et al. Among authors: raterman hg. Ann Rheum Dis. 2023 Oct;82(10):1307-1314. doi: 10.1136/ard-2023-223977. Epub 2023 Aug 4. Ann Rheum Dis. 2023. PMID: 37541762 Clinical Trial.
39 results